Respiratory Tract Diseases Clinical Trial
Official title:
Effect of Volume Guarantee-High Frequency Oscillatory Ventilation on Cerebral Blood Flow in Preterm Neonates
A randomized controlled clinical trial evaluates cerebral blood flow changes associated with HFOV-VG in comparison to HFOV alone in preterm neonates with respiratory insufficiency during the period of invasive respiratory support
Status | Not yet recruiting |
Enrollment | 60 |
Est. completion date | April 30, 2024 |
Est. primary completion date | November 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 1 Day to 1 Month |
Eligibility | Inclusion Criteria: 1. Preterm neonates with gestational age = 35 weeks. 2. Neonates with various causes of respiratory failure: respiratory distress syndrome (RDS), air leak syndromes, pneumonia, or pulmonary hemorrhage, failing with conventional ventilation (i.e. when conventional ventilation failed to maintain either oxygenation or ventilation) and are switched to HFOV as a rescue therapy. Exclusion Criteria: 1. Preterm neonates with major upper or lower airway anomalies. 2. Preterm neonates with significant congenital anomalies including cardiac, abdominal or respiratory |
Country | Name | City | State |
---|---|---|---|
Egypt | Neonatal Intensive Care Units (NICUs), Ain Shams University | Cairo | Abbasia |
Lead Sponsor | Collaborator |
---|---|
Ain Shams University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Doppler cerebral blood flow velocity measurements | Investigate the effect of combining the VG mode with HFOV (HFOV-VG), versus the effect of HFOV alone, on Doppler cerebral blood flow velocity measurements | 72 hours | |
Secondary | efficiency of HFOV-VG in comparison with HFOV alone | Evaluate the efficiency of HFOV-VG in comparison with HFOV alone as a rescue therapy in providing adequate neonatal ventilation and its possible impact on the short-term clinical outcome in terms of mortality and morbidities of these preterm neonates. | 8 weeks or till patient discharged | |
Secondary | Duration of admission | To document total number of days of admission | 8 weeks or till patient discharged | |
Secondary | Mortality rate | To document incidence of mortality during hospitalization | 8 weeks or till patient death which comes first | |
Secondary | Incidence of feeding intolerance | Percentage of Patients who developed feeding intolerance | 8 weeks or till patient discharged | |
Secondary | Days to reach full intake | Number of days needed by each patient to reach full intake | 8 weeks or till patient discharge which comes first | |
Secondary | Chest x ray change | Chest x ray grading of RDS performed to patient before and after the assigned mode to compare lung aeration degree | Before intubation and and after 2 hours on assigned mode |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06004440 -
Real World Registry for Use of the Ion Endoluminal System
|
||
Withdrawn |
NCT04842331 -
PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT)
|
Phase 2/Phase 3 | |
Completed |
NCT02352168 -
Airway Inflammation in Children With Allergic Rhinitis and Intervention
|
N/A | |
Completed |
NCT01860898 -
A Phase I Study of iPS Cell Generation From Patients With COPD
|
N/A | |
Completed |
NCT00984945 -
Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults
|
Phase 1 | |
Completed |
NCT00382408 -
A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001
|
Phase 3 | |
Completed |
NCT01442779 -
Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis
|
Phase 2 | |
Recruiting |
NCT05907564 -
Aventus Thrombectomy System Pulmonary Embolism Clinical Study
|
N/A | |
Not yet recruiting |
NCT05534685 -
Budesonia + Intratracheal Surfactant in Incidence of Bronchopulmonary Dysplasia
|
N/A | |
Completed |
NCT03739112 -
Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly
|
Phase 3 | |
Active, not recruiting |
NCT04170348 -
Daily Vitamin D for Sickle-cell Respiratory Complications
|
Phase 2 | |
Completed |
NCT05056766 -
How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolved According to Propulsion: Control With Each mm of Advancement
|
||
Completed |
NCT01991587 -
Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults
|
Phase 1/Phase 2 | |
Recruiting |
NCT05565872 -
Effects of Supervision During a Community-based Exercise Intervention (Urban Training) in Patients With COPD
|
N/A | |
Completed |
NCT03401463 -
Assesment of the Endotracheal Tube Cuff Pressure Values in ICU Pateints Before and After Training Seminar
|
N/A | |
Recruiting |
NCT02913365 -
Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis
|
N/A | |
Active, not recruiting |
NCT01055990 -
Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients
|
Phase 2 | |
Completed |
NCT00743990 -
Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough
|
N/A | |
Completed |
NCT02198391 -
Study of Echinaforce Junior Tablets in Children With Acute Colds
|
||
Terminated |
NCT04371978 -
Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19
|
Phase 3 |